Document is current
Any future updates will be listed below
-
Authors
Dolan, Sarah C.
Kambanis, P. Evelyna
Stern, Casey M.
Becker, Kendra R.
Breithaupt, Lauren
Gydus, Julia
Smith, Sarah
Misra, Madhusmita
Micali, Nadia
Lawson, Elizabeth A.
Eddy, Kamryn T.
Thomas, Jennifer J.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (K23MH125143, K23MH127465, R01MH108595)
Clinical and Translational Science Center, Harvard University, United States (1UL1TR001102)
Nutrition Obesity Research Center at Harvard, United States (P30DK040561)
- License Information
-
More Information
Article History
Received: 8 June 2023
Accepted: 31 October 2023
First Online: 10 November 2023
Declarations
:
: This study was approved by the Mass General Brigham Institutional Review Board, and all participants (or parent/guardian if minor) provided informed consent to participate.
: Not applicable.
: KRB, KTE, and JJT receive royalties from Cambridge University Press. LB is a consultant for Otsuka Pharmaceuticals. EAL was on the scientific advisory board and has a financial interest in OXT Therapeutics, Inc., a company that developed oxytocin-based therapeutics for metabolic disease; and received an investigator-initiated grant from Tonix Pharmaceuticals. MM receives royalties from UpToDate and served as consultant for Abbvie and Sanofi and on the scientific advisory board for Abbvie and Ipsen.
